Why instos are getting keen on Chinese healthcare PE
More asset owners are looking to support healthcare private equity funds amid the pandemic. But aspiring funds also face rising competition, increasing asset costs and geopolitical risk.
![Why instos are getting keen on Chinese healthcare PE](https://cdn.i.haymarketmedia.asia/?n=finance-asia%2Fcontent%2Fdrug%20science%20research%20medicine.jpg&c=1&h=677&q=100&v=20255907&w=1204)
The global Covid-19 outbreak has directed more institutional investor attention towards healthcare-focused private equity funds, particularly those with a China focus.
Sign In to Your Account
Access Exclusive AsianInvestor Content!
Please sign in to your subscription to unlock full access to our premium AI resources.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial—no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
¬ Haymarket Media Limited. All rights reserved.